A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

Summary

This is an 2-part study. Part 1 will assess the safety, tolerability and pharmacokinetics of single doses of FDL176 with and without co-administration of FDL169. Part 2 will assess the safety, tolerability and pharmacokinetics of repeated doses of FDL176 with and without co-administration of FDL169 .

Timeline

Start

2018-03-07

Primary completion

2018-08-22

Completion

2018-08-22

Drugs

Indications